United States: Federal Circuit PTAB Appeal Statistics Through June 30, 2020 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

31 Aug 2020 0 shares 1 views

United States: Federal Circuit PTAB Appeal Statistics Through June 30, 2020 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

Published 31 Aug 2020

Through June 30, 2020, the Federal Circuit decided 752 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 552 (73.40%) ...

Full Article

United States: Recent Developments In Patent Law: Non-Obviousness Of Chemical And Pharmaceutical Patents - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq 28 Aug 2020

Join a discussion on recent developments in patent law, particularly the non-obviousness of chemical and pharmaceutical patents.

United States: Security People V. Iancu: District Court Lacks Jurisdiction To Hear APA Suit Challenging IPR Constitutionality - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Mondaq 27 Aug 2020
United States: Prosecution Pointer 239 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Mondaq 27 Aug 2020
United States: District Court Lacks Jurisdiction To Hear APA Suit Challenging IPR Constitutionality - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Mondaq 27 Aug 2020
United States: Court Dismisses Intel's And Apple's Federal And State Antitrust Claims Against Patent Assertion Entities, Albeit With Leave Of Court To Amend The Complaint - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Mondaq 26 Aug 2020

United States: Federal Circuit PTAB Appeal Statistics Through June 30, 2020 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

United States: Federal Circuit PTAB Appeal Statistics Through June 30, 2020 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

You might like

Related news coverage

United States: Recent Developments In Patent Law: Non-Obviousness Of Chemical And Pharmaceutical Patents - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Advertisement